Rewriting Life Merck Invests in RNA Startup to Target Cancer If it works, mRNA therapy could provide a simple way to create customized cancer vaccines. by Ryan Cross 2016-07-05T10:49:00-04:00
Rewriting Life Moderna Therapeutics: The Next Genentech? Not so fast. The company has a novel approach, and its funding is commendable, but questions about its RNA technology remain. by Steve Dickman 2012-12-11T07:00:00-05:00